VPhA Foundation Presents NASPA Pharmacy-based Point-of-Care Test & Treat Certificate Program

Live Dates and Location:

Sunday, August 18, 2024 | 1:00pm – 5:00pm EST – Zoom Webinar
Sunday, August 25, 2024 | 1:00pm – 5:00pm EST – Zoom Webinar

Summary:

Point-of-care testing empowers clinicians to use effective, fast technology to aid their decision-making at the “point-of-care” to improve patient health. Pharmacy-based point-of-care testing utilizes CLIA-waived (Clinical Laboratory Improvement Amendments-waived) tests that offer near-immediate results in non-laboratory settings. Pharmacists and pharmacies are increasingly offering this public health service to promote prevention, early detection, treatment, and disease management.

Program note: This program is not tailored to VA law. In VA, pharmacists are exempt from laboratory testing requirements only for CLIA-waived tests that have been approved by the FDA for home use. Nothing in this program shall constitute legal advice, and pharmacists are advised to seek legal counsel prior to undertaking a point-of-care testing program in their pharmacy or entering into any collaborative practice agreements

Registration Information & Rates:

Please contact VPhA Foundation Administrator Jaime York at foundationinfo@virginiapharmacists.org or call the Foundation Office at (804) 302-0131.
Be sure to provide your First/Last Name, Phone Number, Email Address, and your preferred Live Date (choose from above).

VPhA Members: $250
Non-Members: $450

Presenters:

Information COMING SOON

Program Features

  • Practical, hands-on training in point-of-care testing and treatment in at least 12 disease states
  • 20 credit hours of ACPE-accredited continuing education
  • Unique dual home study and in-person structure
  • Access to and training on the interactive, web-based education platform
  • Instructor training necessary to train others on the program

Activity Description

The NASPA Pharmacy-based Point-of-Care Test & Treat National Certificate Program provides an opportunity to gain the skills and information necessary to develop a testing program such as influenza, Group A Streptococcus, HIV, Hepatitis C, coronaviruses, and chronic diseases. The target audience for the certificate program is pharmacists, pharmacy technicians, student pharmacists, academia, and pharmacy association staff. While the program is primarily designed for pharmacists, non-pharmacists interested in point-of-care test and treat are also welcome to complete the program.

The 20-hour ACPE-accredited certificate program includes comprehensive material regarding key disease states, physical assessment, point-of-care tests and treatment, and business models through:

  • 16 hours of home study
  • 4 hours of live training

Participants take an online assessment after each of the 12 modules of home study, in addition to a cumulative assessment (must pass 70% within three attempts), and then their proficiency to conduct physical assessments and offer point-of-care testing services is assessed in the live/virtual training. Upon successful completion of both portions of the program and all program evaluations, participants are awarded a certificate of completion and pharmacists can receive 20 hours of Continuing Pharmacy Education (CPE) credit.

Learning Objectives

At the completion of this activity, the pharmacist will be able to:

  • Identify opportunities for expanding patient-centered services in pharmacy settings, using point-of-care testing and treatment.
  • Discuss the value and limitations of patient reported symptoms, medical history, and drug allergies.
  • Describe and perform the following physical assessments, when appropriate to patient care: Blood Pressure, Pulse, Respiratory Rate, Oxygenation, and Cervical Lymph Node Inspection
  • Describe and perform the following specimen collections used in point of care testing: Throat swab, and Nasal swab
  • Identify characteristics of exemplar infectious diseases (e.g. influenza, Group A Streptococcus, Human Immunodeficiency Virus, Hepatitis C, Coronaviruses) regarding: Causative agents, Transmission, Immunizations, Symptoms and Presentation, Appropriate treatment, Point-of-Care testing.
  • Define and contrast the following terms as they relate to point-of-care testing in pharmacies: CLIA, CLIA-waived, Collaborative Agreement, Protocol, Prescribe, Diagnose.
  • Explain the value and limitations of Point-of-Care Tests, including rapid diagnostic tests, and list the steps a pharmacist can take to improve test performance.
  • Apply all information to patient-specific cases based on common pharmacy-based patient interaction.

At the completion of this activity, the pharmacy technician will be able to:

  • Identify opportunities for expanding patient-centered services in pharmacy settings, using point-of-care testing and treatment.
  • Discuss the value and limitations of patient reported symptoms, medical history, and drug allergies.
  • Describe and perform under the supervision of a pharmacist the following physical assessments, when appropriate to patient care: Blood Pressure, Pulse, Respiratory Rate, Oxygenation, and Cervical Lymph Node Inspection
  • Describe and perform the following specimen collections used in point of care testing: Throat swab, and Nasal swab
  • Identify characteristics of exemplar infectious diseases (e.g. influenza, Group A Streptococcus, Human Immunodeficiency Virus, Hepatitis C, Coronaviruses) regarding: Causative agents, Transmission, Immunizations, Symptoms and Presentation, and Point-of-Care testing.
  • Define and contrast the following terms as they relate to point-of-care testing in pharmacies: CLIA, CLIA-waived, Collaborative Agreement, Protocol, Prescribe, Diagnose.
  • Explain the value and limitations of Point-of-Care Tests, including rapid diagnostic tests.

ACPE credit: Home Study plus Live Training

This course offers 20 hours of ACPE CE (16 home study, 4 live training)

Students take an online assessment after each of the 12 modules of home study, in addition to a cumulative assessment (must pass 70% within three attempts), and then their proficiency to conduct physical assessments and offer point-of-care testing services is assessed in the live training. Upon successful completion of both portions of the program and all program evaluations, participants are awarded a certificate of completion and can receive 20 hours of Continuing Pharmacy Education (CPE) credit.

Please CLICK HERE for a detailed outline of all 12 modules.

Target Audience

This course provides pharmacists, pharmacy technicians, and student pharmacists with the skills necessary to develop a testing program for influenza, Group A streptococcus, HIV, hepatitis C, and Coronavirus.

ACPE Accreditation Information

Michigan Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The home study portion of the program is approved for 16 contact hours and the live training is approved for 4 contact hours of continuing pharmacy education credit. Credit is only awarded for completion of the entire 20 contact hour program. Credit must be claimed within 30 days of completing the program.

 

Cancellation policy
VPhA Foundation is not accepting cancellations. Once registered, no refunds will be offered. Make-up sessions may be considered on availability and demand, but not guaranteed.
If you have questions about this program, please contact VPhA Foundation Administrator Jaime York at foundationinfo@virginiapharmacists.org